Get Permission Kaur and Kaur: Isolation, identification and antibiotic susceptibility pattern of coagulase –negative staphylococci (cons) in various clinical specimens


Introduction

Gram-positive Staphylococci are non-sporing, non-motile cocci that are arranged in clusters that resemble grapes. On the skin and mucous membranes, they often form a normal part of the flora. The most famous member of the family and the most popular coagulase-positive strain is S.aureus. 1 Coagulase-positive and Coagulase-Negative Staphylococcus (CoNS) species are commonly distinguished. Species of Staphylococcus that do not produce an enzyme coagulase are known as coagulase - negative Staphylococci. CoNS are the type of bacteria that frequently live on a person's skin and mucous membranes and are known to be a major cause of human infection.2 About 40 different species of bacteria make up the heterogeneous CoNS group, and several of these have been identified as potential human pathogens.3 S. epidermidis, S. hemolytic, S. saprophyticus and S. hominis are the most often isolated species from human specimens that cause disease. Other species like S.lugdunensis, S. capitis, S. simulans, S. cohnii, S. saccharolyticus, and S. xylosus have been regarded as important opportunistic pathogens but are rarely isolated.4, 5 Currently, CoNS, as typical opportunists, is one of the most dangerous nosocomial, posing a serious threat to human life and health and being responsible for between 27% and 32% and 50% of nosocomial infections in adult and paediatric patients, respectively.6 The risk of contracting CoNS infection increases for surgical patients and hospitalised individuals. 7 People most vulnerable to CoNS infections are those with weakened immune systems. This includes those who have cancer, are elderly, are very young, or have autoimmune diseases and those who have a urinary catheter inserted. 8

About 75 % of all clinical isolates of CoNS are caused by Staphylococcus epidermidis and its emergence as a multiple drug resistance determinant makes patient medical management more challenging. 9 Staphylococci are becoming more and more resistant to antimicrobial treatments. Methicillin resistance in CoNS varies in India from 22.5% to 64.8%. 10, 11, 12

Objectives

  1. To study the prevalence of CoNS in clinical samples of patients in ICUs.

  2. To identify various species of CoNS isolated from clinical samples.

  3. To study the antimicrobial susceptibility pattern of CoNS.

Material and Methods

The Present Study entitled "Isolation, Identification, and Antibiotic Susceptibility Pattern of Coagulase –Negative Staphylococci (CoNS) in Various Clinical Specimens” was conducted in a teaching hospital of Punjab, India. Over six months from October 2021 to March 2022 after the approval from Institutional Research committee and Ethics Committee for Biomedical and Health Research. A total of 1200 various clinical specimens received from different infections from both males and females of all age groups patients admitted in ICU, CCU, NICU, and PICU were processed at the Bacteriology Laboratory of Microbiology department. Samples of blood, wound swabs, pus, drain fluid, tracheal aspirate, peritoneal fluid, pleural fluid, and urine were received. For blood and body fluid, BacT/ALERT 3 D System was used. Blood agar, MacConkey agar and CLED agar media was used as solid culture media for isolation of pathogen. Culture showing significant growth of organism were further processed for identification on the basis of colony characterstics. For all Gram positive cocci, catalase test was performed to differentiate Staphylococci from Streptococci. For all Staphylococci, slide coagulase was done using human plasma to differentiate between coagulase positive and coagulase negative. Coagulase negative Staphylococci were further identified to species level by Vitek 2 Compact system using GP card. For antibiotic susceptibility testing P628 AST Panel was used to assess the antibiotic sensitivity by VITEK-2 compact system. Results were interpreted in accordance with recommendations made by the Clinical Laboratory Standards Institute (CLSI). 13 Clinical data of patients was collected using proforma by taking relevant history and from record files.

Results

During the six-month period between 1 October 2021 to 31 march 2022, a total 1200 clinical sample were received from various intensive care departments (ICU,CCU,PICU,NICU) in bacteriology laboratory of microbiology department for culture and sensitivity. Among these 1200 clinical samples 216 showed significant growth with 52(23.7%) CoNS and 164(76.3%) others bacterial isolates. Isolation of CoNS were more from male patient 32(61.5%) then females 20(38.5%). Samples was distribution was as shown in Table 1.

Table 1

Distribution of CoNS among different clinical samples.

Sample

No. of sample

Percentage

Urine

17

32.7%

Pus

1

1.9%

ET

1

1.9%

Sputum

2

3.8%

Fluid

1

1.9%

Table 2

Speciation profile of coagulase negative Staphylococci:

Species

No. of isolate

Percentage (%)

S.heamolytic

28

54%

S.saprophyticus

8

15%

S.hominis

8

15%

S. S.epidermitidis

8

15%

Table 3

Antibiogram of different species of CoNS

Antibiotics

S.hemolyticus

S.epidermitidis

S.hominis

S.saprophyticus

S

R

S

R

S

R

S

R

Benzylpenicillin

3(11%)

25(89%)

2(25%)

6(75%)

2(25%)

6(75%)

2(25%)

6(75%)

Oxacillin

7(25%)

21(75%)

5(63%)

3(37%)

2(25%)

6(75%)

5(63%)

3(37%)

Gentamicin

11(39%)

17(61%)

4(50%)

6(50%)

7(88%)

1(12%)

4(50%)

6(50%)

Ciprofloxacin

10(36%)

18(64%)

2(25%)

6(75%)

3(38%)

5(62%)

2(25%)

6(75%)

Levofloxacin

7(25%)

21(75%)

4(50%)

4(50%)

4(50%)

4(50%)

4(50%)

4(50%)

Erythromycin

7(25%)

21(75%)

6(75%)

2(25%)

6(75%)

2(25%)

6(75%)

2(25%)

Clindamycin

12(43%)

16(57%)

7(88%)

1(12%)

6(75%)

2(25%)

7(88%)

1(12%)

Cotrimazodole

14(50%)

14(50%)

8(99%)

-

7(87%)

1(13%)

8(99%)

-

Linezolid

16(57%)

12(43%)

8(99%)

-

7(87%)

1(13%)

8(99%)

-

Daptomycin

18(64%)

10(46%)

8(99%)

-

6(75%)

2(25%)

8(90%)

-

Teicoplanin

18(64%)

10(46%)

8(99%)

-

6(75%)

2(25%)

8(99%)

-

Vancomycin

18(64%)

10(46%)

8(98%)

-

7(87%)

1(13%)

8(98%)

-

Tetracycline

16(57%)

12(53%)

8(98%)

-

6(75%)

2(25%)

8(99%)

-

Tigecycline

16(57%)

12(53%)

8(99%)

-

1(12%)

7(88%)

8(97%)

-

Nitrofurantion

14(50%)

14(50%)

8(98%)

-

6(75%)

2(25%)

8(97%)

-

Rifampicin

11(50%)

11(50%)

4(50%)

-

1(12%)

7(88%)

4(50%)

50

Discussion

A total of 1200 clinical samples were received from various ICUS52 CoNS were isolated. The prevalence of CoNS infection in present study was found to be 23.7% which is very high. A similar results was found by a Bora P (2018) reported that out of 120 samples 68 isolates were CoNS with 56% prevalence. A study by Kumar S. (2018) reported that out of 400 clinical samples, 60 isolates were as CoNS with 15% prevalence and a study by Ariel E Stella (2020) reported that out of 276 clinical samples, 58 isolated were coagulase negative Staphylococci with 19% prevalence which are less than the present study. The present study showed the CoNS infection isolates out numbered in males 32(61.5%) then females 20(38.5%) This may be due to more hospital admission of male patients. In the present study maximum isolation of CoNS was from blood 30(57.7%) followed by sputum 2(3.8%) urine 17(32.7%), pus 1(1.9%) body fluid 1(1.9%.)(Table 1). A Study by Qadar.S et.al shows the result of sample collection as from urine 31%, pus 2.0%, sputum 2.8%, fluid 2.0% and from blood 55.5% which is almost similar to present study. 14 A Study by Mila V.S et al and Ibrahim et al are less then the present study.

Table 4

Species wise distribution reported by different studies comparative to present study.

Species

Present study

Mohan et al

Mila V.S et al

Qader et al

S.hemolyticus

(28)54%

52%

20%

35%

S. saprophyticus

(8)15%

18%

27%

29%

S.epi dermitidis

(8)15%

16%

40%

59%

S.hominis

(8)15%

11%

15%

9%

In our study S. hemolyticus was highest 54% followed while others like S.saprophyticus, S.epidermitidis, S.hominis (Table 2) A stella and mohan et.al showing similar studies but a study by Qadar et.al is less then to present study.

Antibiotic susceptibility pattern (Table 3)

According to the current study's analysis of CoNS species' susceptibility to antibacterial agents, S.hemolyticus is more susceptible to the antibacterial drugs tigecyclin 18 (65%) and vancomycin 18 (64%), while studies by Ahmed et al and Mila V.S. et al. found lower susceptibilities to these drugs than did the present study.

S.epidermitidis, which is very responsive to Daptomycin 8 (99%) and Tetracycline 8 (99%) as well as Gentamicin 90% and Daptomycin 85%, according to a research by Ahmed et al. 15 A study by Mila V.S. et al. found that gentamicin is only 65 percent effective against penicillin-resistant bacteria.

In the current study, S. hominis is very sensitive to Vancomycin 6 (75 %), Daptomycin 7 (87 percent), and Tigecycline 6 (75%)(Table 3). In contrast, a study by Prapti found that S. hominis is sensitive to Daptomycin 90%, Vancomycin 92 %, and Gentamicin 54% and study by Ibrahim et al which is 75% daptomycin and 80% vancomycin resistant.16

In the current study S. saprophyticus sensitivity to Linezolid 8 (99%), Daptomycin 8 (99%).(Table 3) and a comparable study by Mila V.S et al. that is Daptomycin 98% and Linezolid 98% are all very toxic to S. Saprophyticus.17 According to a study by Ibrahim Ali et al, 46% of the sample was resistant to Gentamycin and 34% to Vancomycin.

Conclusion

The current study shown that pathogenic coagulase-negative Staphylococci cause infection-related signs and symptoms. CoNS was discovered to be isolated from blood, urine, and pus, and S. hemolyticus, S. epidermitidis, S. homoinis, and S. saprophyticus were the most often found species in patients.

The majority of the isolates of S.hemolyticus came from cultures. Most patients in CCUs who develop CoNS infection do so. Those, those with central lines and ventilators, and patients with post-operative wounds. Vancomycin and gentamycin are very efficient against a group of microorganisms that are very resistant to penicillin and amoxicillin.

Source of Funding

None.

Conflicts of Interest

There is no conflict of interest.

References

1 

BH Harmory JT Parisi JP Hutton Staphylococcus epidermidis a significant pathogenAm J Infect Control19871525974

2 

P Boerlin P Kuhnert D Hüssy M Schaellibaum Methods for identification of Staphylococcus aureus isolates in cases of bovine mastitisJ Clin Microbiol20034127677110.1128/JCM.41.2.767-771.2003

3 

SS Senger ME Saccozza A Yce Compatibility of pulsed-field gel electrophoresis findings and clinical criteria commonly used to distinguish between true coagulase-negative staphylococcal bacteremia and contaminationInfect Control Hosp Epidemiol2007288992610.1086/518753

4 

L May EY Klein RE Rothman Trends in antibiotic resistance in coagulase-negative Staphylococci in the united statesAntimicrob Agents Chemother20145831404910.1128/AAC.01908-13

5 

R Sarathbabu N Rajkumari TV Ramani Characterization of coagulase - negative Staphylococci isolated from urine, pus, sputum and blood samplesInt J Pharm Sci Invention2013213746

6 

O Bouchami W Achour AB Hassen A Species distribution and antibiotic sensitivity pattern of coagulase -negative Staphylococci other than Staphylococcus epidermidis isolated from various clinical specimensAfr J Microbiol Res2011529830510.5897/AJMR11.112

7 

T Nowak E Baclcerczak M Mirowski EM Szewczyk Detection of methicillin resistance in hospital environmental strains of coagulase-negative staphylococciPol J Microbiol200655433943

8 

BL Bearson JA Labarca LE Brankovic M Cohena DA Brucknera DA Peguesb Use of quantitative antibiogram analysis to determine the colonality of coagulase negative Staphylococcus species from blood cultureClin Microbiol Infect20041021485510.1111/j.1469-0691.2004.00753.x

9 

R Goyal NP Singh A Kuma I Kaur M Singh N Sunita Simple and economical method for speciation and resistotyping of clinically significant coagulase negative staphylococciIntl J Med Med Sci20062432014

10 

A Chaudhury A G Kumar In vitro activity of antimicrobial agents against oxacillin resistant Staphylococci with special refrence to Staphylococci haemolyticusIndia J Med MIcrobiol2007255052

11 

RH Deurenberg C Vink S Kalenic AW Friedrich CA Bruggeman EE Stobberingh The molecular evolution of Methicillin Resistant Staphylococcus aureusClin Microbiol Infect20071332223510.1111/j.1469-0691.2006.01573.x

12 

KB Anand Agrawal Kumars Comparison of cefoxitin disc diffusion test,oxacillin screen agar,and PCR for mecA gene for detection of MRSAIndian J Med MIcrobiol2009271279

13 

M Lertcanawanichakul K Chawawisit A Choopan Incidence of constitutive and inducible Clindamycin resistance in clinical isolates of Methicillin Resistant Staphylococcus aureuswalailak j sci technol20074155163

14 

U Mohan N Jindal P Aggarwal Species Distribution and Antibiotic sensitivity pattern of coagulase negative Staphylococci isolated from various clinical specimensIndian J Med Microbiol2002201456

15 

TY Tan SY Ng WX Ng clinical significance of coagulase negative Staphylococci recovered from nonsterile siteJ Clin Microbiol20024493413410.1128/JCM.00757-06

16 

Y Kawamura XG Hou F Sultana K Hirose M Miyake SE Shu Distribution of Staphylococcus species among human clinical specimens and emended description of Staphylococcus capreaJ Clin Microbiol199836720384210.1128/JCM.36.7.2038-2042.1998



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 25-08-2022

Accepted : 28-10-2022


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijmmtd.2022.060


Article Metrics






Article Access statistics

Viewed: 699

PDF Downloaded: 219



Medical Abbreviation List